In this article

LLY

Follow your favorite stocks CREATE FREE ACCOUNT

Eli Lilly on Tuesday said it will spend $6 billion to build a manufacturing plant in Huntsville, Alabama, to help boost production of its closely watched experimental obesity pill and other drugs.

It is the third facility in a string of new planned U.S. investments by the drugmaker. Eli Lilly announced in February that it would spend at least $27 billion to build four new domestic manufacturing plants, adding to $23 billion in previous investments since 2020.

The company said it expects construction of the Alabama plant to start in 2026 and for it to be completed in 2032.

"Today's investment continues the onshoring of active pharmaceutical ingredient (API) production, strengthening supply chain resili

See Full Page